MIRANDA ANGERMEIER: Open Payments
NPI 1649949611 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,547 in 170 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $2,456 · 2025 $3,547
Food & beverage: $3,436Education: $111
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $371 |
| ABBVIE INC. | 24 | $352 |
| UCB, Inc. | 26 | $346 |
| Alexion Pharmaceuticals, Inc. | 7 | $301 |
| Teva Pharmaceuticals USA, Inc. | 10 | $263 |
| PFIZER INC. | 13 | $215 |
| Biogen, Inc. | 11 | $188 |
| Otsuka America Pharmaceutical, Inc. | 3 | $175 |
| Lundbeck LLC | 12 | $172 |
| SK Life Science, Inc. | 5 | $168 |
Products named: KISUNLA, ULTOMIRIS, REXULTI, QULIPTA, NURTEC ODT, Briviact, ZEPOSIA, VUMERITY.
Industry payments across AZ — which companies pay providers there.
